TGFB1 and colorectal carcinoma: Increased TGF-β in the tumor microenvironment predicts adverse outcomes in CRC patients, partly due to the TGF-β-induced immune evasion mechanism that promotes T cell exclusion and blocks the acquisition of the Th1 effector phenotype [28].